Subsequently, we provided evidence that knockdown of SLC6A14 expression or treatment with α-MT reduced CRC cell proliferation and migration in vitro through restricting amino acids uptake and inhibited xenograft tumor growth in vivo. Here, SLC6A14 is linked to colorectal carcinoma.